Royalty and Commercial Payment Purchase Agreements (Tables)

6 Months Ended

Jun. 30, 2024

Royalty and Commercial Payment Purchase Agreements

Summary of royalty and commercial payment receivable activities

The following table summarizes the royalty and commercial payment receivable activities during the six months ended June 30, 2024 (in thousands):

	Short-Term		Long-Term
Balance as of January 1, 2024	$	14,215	$	57,952
Acquisition of royalty and commercial payment receivables:
Talphera		—		8,000
Daré		—		22,000
Receipt of royalty and commercial payments:
Viracta		—		(8,500)
Affitech		(7,396)		—
Aptevo		(794)		—
Talphera		—		(51)
Income from purchased receivables under effective interest rate method:
Affitech		4,562		—
Reclassification to short-term royalty and commercial payment receivables:
Aptevo		670		(670)
Recognition of contingent consideration:
Affitech		3,000		—
Impairment of royalty and commercial payment receivables:
Aronora				(9,000)
Balance as of June 30, 2024	$	14,257	$	69,731